TEX46 and cancer: By identifying novel m6A-TEX subtypes and exploring their biological and immunological features, our study not only expands the understanding of TEX dynamics but also highlights the potential of m6A regulators as biomarkers and therapeutic targets to improve cancer immunotherapy.